These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2166359)
1. Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers. Bergstrand H; Björnson A; Blaschke E; Brattsand R; Eklund A; Larsson K; Linden M Thorax; 1990 May; 45(5):362-8. PubMed ID: 2166359 [TBL] [Abstract][Full Text] [Related]
2. The effects of an inhaled corticosteroid on oxygen radical production by bronchoalveolar cells after allergen or ozone in dogs. Stevens WH; Adelroth E; Woolley MJ; Wattie J; Dahlbäck M; O'Byrne PM Eur J Pharmacol; 1995 Oct; 293(3):251-7. PubMed ID: 8666043 [TBL] [Abstract][Full Text] [Related]
4. Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers. Linden M; Wieslander E; Eklund A; Larsson K; Brattsand R Eur Respir J; 1988 Jul; 1(7):645-50. PubMed ID: 2846345 [TBL] [Abstract][Full Text] [Related]
5. Effects of beta2-agonists and budesonide on interleukin-1beta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages. Zetterlund A; Linden M; Larsson K J Asthma; 1998; 35(7):565-73. PubMed ID: 9777883 [TBL] [Abstract][Full Text] [Related]
6. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. Martin TR; Raugi G; Merritt TL; Henderson WR J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074 [TBL] [Abstract][Full Text] [Related]
7. Effects of smoking on the synthesis of leukotriene B4 by rat alveolar macrophages. Sugiyama Y; Izumi T; Ohishi N; Yotsumoto H; Shimizu T; Kitamura S; Takaku F Respiration; 1989; 56(3-4):198-203. PubMed ID: 2561408 [TBL] [Abstract][Full Text] [Related]
8. Stimuli-induced superoxide radical generation in vitro by human alveolar macrophages from smokers: modulation by N-acetylcysteine treatment in vivo. Bergstrand H; Björnson A; Eklund A; Hernbrand R; Larsson K; Linden M; Nilsson A J Free Radic Biol Med; 1986; 2(2):119-27. PubMed ID: 3029208 [TBL] [Abstract][Full Text] [Related]
9. LTB4 production and lysosomal enzyme release by rat alveolar macrophages: effects of phagocytosis, receptor binding, and ionophore stimulation. Hsueh W; Gonzalez-Crussi F; Henderson S Exp Lung Res; 1987; 13(4):385-99. PubMed ID: 2834192 [TBL] [Abstract][Full Text] [Related]
10. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis. De Rose V; Trentin L; Crivellari MT; Cipriani A; Gialdroni Grassi G; Pozzi E; Folco G; Semenzato G Thorax; 1997 Jan; 52(1):76-83. PubMed ID: 9039241 [TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Yoss EB; Spannhake EW; Flynn JT; Fish JE; Peters SP Am J Respir Cell Mol Biol; 1990 Jan; 2(1):69-80. PubMed ID: 2155013 [TBL] [Abstract][Full Text] [Related]
12. Characterization of arachidonic acid metabolism, superoxide production, and bacterial killing by bovine alveolar neutrophils elicited with leukotriene B4 and zymosan-activated plasma. Heidel JR; Taylor SM; Silflow RM; Laegreid WW; Leid RW Inflammation; 1991 Feb; 15(1):31-42. PubMed ID: 1647369 [TBL] [Abstract][Full Text] [Related]
13. Depression of stimulated arachidonate metabolism and superoxide production in rat alveolar macrophages following in vivo exposure to 0.5 ppm NO2. Robison TW; Murphy JK; Beyer LL; Richters A; Forman HJ J Toxicol Environ Health; 1993 Mar; 38(3):273-92. PubMed ID: 8383773 [TBL] [Abstract][Full Text] [Related]
14. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4. Garcia JG; Griffith DE; Cohen AB; Callahan KS Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249 [TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Martin TR; Altman LC; Albert RK; Henderson WR Am Rev Respir Dis; 1984 Jan; 129(1):106-11. PubMed ID: 6322626 [TBL] [Abstract][Full Text] [Related]
16. Lung type II cell and macrophage annexin I release: differential effects of two glucocorticoids. Hall SE; Lim S; Witherden IR; Tetley TD; Barnes PJ; Kamal AM; Smith SF Am J Physiol; 1999 Jan; 276(1):L114-21. PubMed ID: 9887063 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke. Tardif J; Borgeat P; Laviolette M Am J Respir Cell Mol Biol; 1990 Feb; 2(2):155-61. PubMed ID: 2155016 [TBL] [Abstract][Full Text] [Related]
18. Budesonide but not terbutaline decreases phagocytosis in alveolar macrophages. Zetterlund A; Larsson PH; Müller-Suur C; Palmberg L; Larsson K Respir Med; 1998 Feb; 92(2):162-6. PubMed ID: 9616506 [TBL] [Abstract][Full Text] [Related]
19. beta2-Adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide. Zetterlund A; Hjemdahl P; Larsson K Clin Sci (Lond); 2001 Apr; 100(4):451-7. PubMed ID: 11256987 [TBL] [Abstract][Full Text] [Related]
20. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. Martin TR; Pistorese BP; Chi EY; Goodman RB; Matthay MA J Clin Invest; 1989 Nov; 84(5):1609-19. PubMed ID: 2553777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]